Cargando…
A feasibility study to identify proteins in the residual Pap test fluid of women with normal cytology by mass spectrometry-based proteomics
BACKGROUND: The proteomic analysis of body fluids is a growing technology for the identification of protein biomarkers of disease. Given that Papanicolaou tests (Pap tests) are routinely performed on over 30 million women annually in the U.S. to screen for cervical cancer, we examined the residual P...
Autores principales: | Boylan, Kristin LM, Afiuni-Zadeh, Somaieh, Geller, Melissa A, Hickey, Kayla, Griffin, Timothy J, Pambuccian, Stefan E, Skubitz, Amy PN |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4106909/ https://www.ncbi.nlm.nih.gov/pubmed/25097468 http://dx.doi.org/10.1186/1559-0275-11-30 |
Ejemplares similares
-
Evaluation of the potential of Pap test fluid and cervical swabs to serve as clinical diagnostic biospecimens for the detection of ovarian cancer by mass spectrometry-based proteomics
por: Boylan, Kristin L. M., et al.
Publicado: (2021) -
Evaluating the potential of residual Pap test fluid as a resource for the metaproteomic analysis of the cervical-vaginal microbiome
por: Afiuni-Zadeh, Somaieh, et al.
Publicado: (2018) -
Quantitative proteomic analysis by iTRAQ(® )for the identification of candidate biomarkers in ovarian cancer serum
por: Boylan, Kristin LM, et al.
Publicado: (2010) -
Identification of heterogeneity among soft tissue sarcomas by gene expression profiles from different tumors
por: Skubitz, Keith M, et al.
Publicado: (2008) -
Mathematical Prognostic Biomarker Models for Treatment Response and Survival in Epithelial Ovarian Cancer
por: Nikas, Jason B., et al.
Publicado: (2011)